Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing flexible-dose extended-release paliperidone to quetiapine and placebo in adults with Bipolar I disorder has completed, assessing effic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Paliperidone ER (Invega) (paliperidone)
• Quetiapine (Seroquel) (quetiapine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Bipolar Disorder, Mood Disorders | Phase 3 | Status: COMPLETED